Article
Systems biology of cisplatin resistance: past, present and future
29 May 2014
Abstract excerpt
The platinum derivative cis-diamminedichloroplatinum(II), best known as cisplatin, is currently employed for the clinical management of patients affected by testicular, ovarian, head and neck, colorectal, bladder and lung cancers. For a long time, the antineoplastic effects of cisplatin have been fully ascribed to its ability to generate unrepairable DNA lesions, hence inducing either a permanent proliferative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
